ZNF788 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.99350000343424E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.154900E-04 |
Normal-vs-Stage2 |
3.623600E-04 |
Normal-vs-Stage3 |
7.03126445955604E-12 |
Normal-vs-Stage4 |
2.62420000174401E-08 |
Stage1-vs-Stage2 |
1.969850E-01 |
Stage1-vs-Stage3 |
4.39869999999676E-05 |
Stage1-vs-Stage4 |
4.396700E-03 |
Stage2-vs-Stage3 |
1.343200E-01 |
Stage2-vs-Stage4 |
3.123000E-01 |
Stage3-vs-Stage4 |
6.945400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.02810000407661E-08 |
Normal-vs-AfricanAmerican |
3.53050000345689E-08 |
Normal-vs-Asian |
9.959400E-01 |
Caucasian-vs-AfricanAmerican |
4.883100E-03 |
Caucasian-vs-Asian |
1.454010E-01 |
AfricanAmerican-vs-Asian |
2.730000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.31880000253659E-08 |
Normal-vs-Female |
1.5951999998709E-07 |
Male-vs-Female |
9.834400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.979300E-03 |
Normal-vs-Age(41-60Yrs) |
4.92450000000311E-06 |
Normal-vs-Age(61-80Yrs) |
2.58710053380184E-10 |
Normal-vs-Age(81-100Yrs) |
6.230200E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.399200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.853800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.976400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.900100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.091400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.234400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.508400E-01 |
Normal-vs-Grade 2 |
5.554400E-04 |
Normal-vs-Grade 3 |
1.56390000949358E-09 |
Normal-vs-Grade 4 |
9.6078700551061E-13 |
Grade 1-vs-Grade 2 |
1.011810E-01 |
Grade 1-vs-Grade 3 |
2.615500E-02 |
Grade 1-vs-Grade 4 |
2.984900E-04 |
Grade 2-vs-Grade 3 |
4.878300E-03 |
Grade 2-vs-Grade 4 |
2.52879999995681E-06 |
Grade 3-vs-Grade 4 |
5.920500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.361600E-03 |
Normal-vs-ccB subtype |
5.66610092178621E-11 |
ccA subtype-vs-ccB subtype |
2.48769999999787E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.09470000526125E-08 |
Normal-vs-N1 |
2.279900E-02 |
N0-vs-N1 |
4.180800E-01 |
|
|